title: Effect of diabetes mellitus on mouse pre-implantation embryo development.
abstract: Fifteen spontaneously diabetic, non-obese mice (NOD strain), 17 non-diabetic NOD mice (in which diabetes had not yet developed) and 9 diabetic NOD mice were treated with insulin. All animals were superovulated with 5 iu of pregnant mares' serum gonadotrophin followed 48 h later by 5 iu human chorionic gonadotrophin (hCG) and mated overnight with NOD males of proven fertility. To assess in-vitro and early in-vivo development, 23 NOD mice were killed 72 h after hCG treatment. Embryos were recovered from oviduct flushings and cultured in Ham's F-10 medium with 0.1% bovine serum albumin at 37 degrees C in an atmosphere of 5% O2, 5% CO2, and 90% N2. Development was assessed at intervals of 24 h for 72 h. Compared with embryos from non-diabetic NOD mice (n = 81), embryos from diabetic NOD mice (n = 68) demonstrated marked impairment in growth assessed by distribution of developmental stages at each observation period (24, 48, 72 h, all P less than 0.001) and by overall rates of progression of developmental stages (P less than 0.01). In diabetic NOD mice treated with insulin, embryo development (n = 7) was not significantly different from that of embryos from non-diabetic NOD mice (n = 81), but was significantly faster than in embryos from diabetic NOD mice not treated with insulin (n = 68) (P less than 0.001, for all periods, overall rate P less than 0.01). To assess late in-vivo growth, 18 NOD mice were killed 120 h after hCG.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06510.
authors.forename: K H
authors.initials: KH
authors.lastname: Moley
authors.forename: W K
authors.initials: WK
authors.lastname: Vaughn
authors.forename: A H
authors.initials: AH
authors.lastname: DeCherney
authors.forename: M P
authors.initials: MP
authors.lastname: Diamond
mesh_terms: D000818:Animals; D001755:Blastocyst / Q000502:physiology*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000196:embryology*; D047108:Embryonic Development; D005314:Embryonic and Fetal Development / Q000187:drug effects / Q000502:physiology*; D005260:Female; D007328:Insulin / Q000627:therapeutic use; D051379:Mice; D016688:Mice, Inbred NOD; D011247:Pregnancy
chemical_list: D007328:Insulin